Skip to content
10-Q/A

Quarterly Report

TONGLI PHARMACEUTICALS (USA), INC.

0001144204-11-051162

← back to feed
Filed
Sep 2, 2011 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Stockholders Equity Q1 2011 · Jun 30, 2011 $16.93M
Stockholders Equity Q1 2011 · Mar 31, 2011 $15M
Current Liabilities Q1 2011 · Jun 30, 2011 $1.83M
Current Liabilities Q1 2011 · Mar 31, 2011 $1.79M
Current Assets Q1 2011 · Jun 30, 2011 $5.75M
Current Assets Q1 2011 · Mar 31, 2011 $3.98M
Total Assets Q1 2011 · Jun 30, 2011 $19.68M
Total Assets Q1 2011 · Mar 31, 2011 $17.87M
Shares Outstanding Q1 2011 · Aug 19, 2010 11.79M sh
Operating Cash Flow Q1 2011 · Jun 30, 2010 $27.88K
Sga Expense Q1 2011 · Jun 30, 2010 $87.08K
Net Income Q1 2011 · Jun 30, 2010 $938.65K
Operating Income Q1 2011 · Jun 30, 2010 $1.28M
Gross Profit Q1 2011 · Jun 30, 2010 $1.42M
Cost Of Revenue Q1 2011 · Jun 30, 2010 $1.79M